ParkinsonCanadaV1, Main, Exploration, bibRecord, 003593

Botulinum toxin A as treatment for drooling saliva in PD

Identifieur interne : 003593 ( Main/Exploration ); précédent : 003592; suivant : 003594

Botulinum toxin A as treatment for drooling saliva in PD

Auteurs : P. K. Pal [Canada] ; D. B. Calne [Canada] ; S. Calne [Canada] ; J. K. C. Tsui [Canada]

Source :

Neurology [ 0028-3878 ] ; 2000.

RBID : Pascal:00-0076855

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Sialorrhée, Botulisme, Toxine, Bontoxilysin, Voie locale, Glande parotide, Traitement, Complication, Personne âgée, Bave.
Wicri :
- topic : Personne âgée.

English descriptors

KwdEn :
- Aged, Aged, 80 and over, Bontoxilysin, Botulinum Toxins, Type A (therapeutic use), Botulism, Complication, Elderly, Female, Humans, Injections, Local administration, Male, Middle Aged, Parkinson Disease (complications), Parkinson disease, Parotid Gland (drug effects), Parotid Gland (secretion), Parotid gland, Saliva (drug effects), Saliva (secretion), Sialorrhea, Sialorrhea (drug therapy), Sialorrhea (etiology), Toxin, Treatment, Treatment Outcome.
MESH :
- chemical , therapeutic use : Botulinum Toxins, Type A.
- complications : Parkinson Disease.
- drug effects : Parotid Gland, Saliva.
- drug therapy : Sialorrhea.
- etiology : Sialorrhea.
- secretion : Parotid Gland, Saliva.
- Aged, Aged, 80 and over, Female, Humans, Injections, Male, Middle Aged, Treatment Outcome.

Abstract

Article abstract-The authors evaluated intraparotid injections of botulinum toxin A in reducing salivary secretions and drooling in nine patients with PD. There was a marked objective reduction in secretion, and two thirds of the patients had subjective improvement in drooling. No side effects were observed. The authors conclude that botulinum toxin A promises to be a simple and effective treatment for the common problem of drooling saliva in chronic neurologic disease.

Affiliations:

Canada

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Botulinum toxin A as treatment for drooling saliva in PD</title>
<author><name sortKey="Pal, P K" sort="Pal, P K" uniqKey="Pal P" first="P. K." last="Pal">P. K. Pal</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurodegenerative Disorders Centre, UBC Hospital</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, BC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Calne, D B" sort="Calne, D B" uniqKey="Calne D" first="D. B." last="Calne">D. B. Calne</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurodegenerative Disorders Centre, UBC Hospital</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, BC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Calne, S" sort="Calne, S" uniqKey="Calne S" first="S." last="Calne">S. Calne</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurodegenerative Disorders Centre, UBC Hospital</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, BC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tsui, J K C" sort="Tsui, J K C" uniqKey="Tsui J" first="J. K. C." last="Tsui">J. K. C. Tsui</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurodegenerative Disorders Centre, UBC Hospital</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, BC</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0076855</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0076855 INIST</idno>
<idno type="RBID">Pascal:00-0076855</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D21</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000003</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000C03</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000C03</idno>
<idno type="wicri:doubleKey">0028-3878:2000:Pal P:botulinum:toxin:a</idno>
<idno type="wicri:Area/Main/Merge">003B37</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10636161</idno>
<idno type="wicri:Area/PubMed/Corpus">001667</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001667</idno>
<idno type="wicri:Area/PubMed/Curation">001667</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001667</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001667</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001667</idno>
<idno type="wicri:Area/Ncbi/Merge">000069</idno>
<idno type="wicri:Area/Ncbi/Curation">000069</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000069</idno>
<idno type="wicri:doubleKey">0028-3878:2000:Pal P:botulinum:toxin:a</idno>
<idno type="wicri:Area/Main/Merge">003903</idno>
<idno type="wicri:Area/Main/Curation">003593</idno>
<idno type="wicri:Area/Main/Exploration">003593</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Botulinum toxin A as treatment for drooling saliva in PD</title>
<author><name sortKey="Pal, P K" sort="Pal, P K" uniqKey="Pal P" first="P. K." last="Pal">P. K. Pal</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurodegenerative Disorders Centre, UBC Hospital</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, BC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Calne, D B" sort="Calne, D B" uniqKey="Calne D" first="D. B." last="Calne">D. B. Calne</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurodegenerative Disorders Centre, UBC Hospital</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, BC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Calne, S" sort="Calne, S" uniqKey="Calne S" first="S." last="Calne">S. Calne</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurodegenerative Disorders Centre, UBC Hospital</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, BC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tsui, J K C" sort="Tsui, J K C" uniqKey="Tsui J" first="J. K. C." last="Tsui">J. K. C. Tsui</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurodegenerative Disorders Centre, UBC Hospital</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, BC</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Bontoxilysin</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Botulism</term>
<term>Complication</term>
<term>Elderly</term>
<term>Female</term>
<term>Humans</term>
<term>Injections</term>
<term>Local administration</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson disease</term>
<term>Parotid Gland (drug effects)</term>
<term>Parotid Gland (secretion)</term>
<term>Parotid gland</term>
<term>Saliva (drug effects)</term>
<term>Saliva (secretion)</term>
<term>Sialorrhea</term>
<term>Sialorrhea (drug therapy)</term>
<term>Sialorrhea (etiology)</term>
<term>Toxin</term>
<term>Treatment</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Parotid Gland</term>
<term>Saliva</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Sialorrhea</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Sialorrhea</term>
</keywords>
<keywords scheme="MESH" qualifier="secretion" xml:lang="en"><term>Parotid Gland</term>
<term>Saliva</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Injections</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Sialorrhée</term>
<term>Botulisme</term>
<term>Toxine</term>
<term>Bontoxilysin</term>
<term>Voie locale</term>
<term>Glande parotide</term>
<term>Traitement</term>
<term>Complication</term>
<term>Personne âgée</term>
<term>Bave</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Personne âgée</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Article abstract-The authors evaluated intraparotid injections of botulinum toxin A in reducing salivary secretions and drooling in nine patients with PD. There was a marked objective reduction in secretion, and two thirds of the patients had subjective improvement in drooling. No side effects were observed. The authors conclude that botulinum toxin A promises to be a simple and effective treatment for the common problem of drooling saliva in chronic neurologic disease.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Pal, P K" sort="Pal, P K" uniqKey="Pal P" first="P. K." last="Pal">P. K. Pal</name>
</noRegion>
<name sortKey="Calne, D B" sort="Calne, D B" uniqKey="Calne D" first="D. B." last="Calne">D. B. Calne</name>
<name sortKey="Calne, S" sort="Calne, S" uniqKey="Calne S" first="S." last="Calne">S. Calne</name>
<name sortKey="Tsui, J K C" sort="Tsui, J K C" uniqKey="Tsui J" first="J. K. C." last="Tsui">J. K. C. Tsui</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003593 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003593 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:00-0076855
   |texte=   Botulinum toxin A as treatment for drooling saliva in PD
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Botulinum toxin A as treatment for drooling saliva in PD

Botulinum toxin A as treatment for drooling saliva in PD

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.